• Mobile: +886 2550-3366
  • Mail: tunglingli@neucen.com
  • EN
  • CN
  • Home
  • About NeuCen
  • Research Group
  • Products
    • NEU
    • CEN
  • News
  • Contact
  • Slide Image
    –Innovation for New Era
    Develop market-leading new drugs
    Focus on new drug innovation, drug delivery innovation, safety and efficacy
    More
     –Innovation for New Era
  • Slide Image
    –Innovation for New Era
    Develop market-leading new drugs
    Focus on new drug innovation, drug delivery innovation, safety and efficacy
    More
     –Innovation for New Era
  • Slide Image
    –Innovation for New Era
    Develop market-leading new drugs
    Focus on new drug innovation, drug delivery innovation, safety and efficacy
    More
     –Innovation for New Era
    Innovation for New Era
Products Information
CEN501

CEN501

nasal immunotherapy kit for allergic rhinitis

  • Time 2022-07-25
  • Read More
NEU001

NEU001

innovative new drug for nasopharyngeal carcinoma.

  • Time 2022-07-25
  • Read More

News

  • 2022-07-22
  • NeuCen Biomed. won the Golden Ship Award of the ROC Chamber of Commerce
  • 2022-07-15
  • NeuCen selected to participate in “Stars of NTU-Fudan” DEMO DAY
  • 2022-06-22
  • NeuCen Biomed. obtained Taiwan patent for CEN501 Drug Carrier
  • 2022-03-22
  • NeuCenBiomed.’ s application for clinical trial has been approved by TVGH-IRB.
  • Read More
Partner
美國NeOnc Technologies, Inc.
合世生醫科技股份有限公司
美國南加州大學Tom Chen教授研發團隊
台灣財團法人生物技術開發中心(DCB)
國立清華大學
國立成功大學
台中榮民總醫院
Copyright © 2015 NEUCEN All Rights Reserved
  • EN
  • CN